Effect of food on the bioavailability of SDZ DJN 608, an oral hypoglycemic agent, from a tablet and a liquid-filled capsule in the dog

Pharmaceutical Research

Volumn 13, Issue 3, 1996, Pages 440-444

  Tse, Francis L S ^a   Labbadia, D ^a   Habucky, K ^a   Karara, A ^a   Au, S ^a  

^a Sandoz Pharma Ltd   (Switzerland)

Author keywords

Bioavailability; Caco 2 cell model; Dissolution; Dosage form; Food; Hypoglycemic

Indexed keywords

NATEGLINIDE; ORAL ANTIDIABETIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; COLON CARCINOMA; CONTROLLED STUDY; DISSOLUTION; DOG; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG TRANSPORT; FOOD DRUG INTERACTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROCAPSULE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TABLET;

ADMINISTRATION, ORAL; AMINO ACID TRANSPORT SYSTEMS; ANIMALS; BIOLOGICAL AVAILABILITY; CACO-2 CELLS; CAPSULES; CARRIER PROTEINS; DOGS; EPITHELIUM; FOOD; HUMANS; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; MALE; PHENYLALANINE; TABLETS;

EID: 0029878650     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016004928627     Document Type: Article

References (14)

1. H. Shinkai, M. Nishikawa, Y. Sato, K. Toi, I. Kumashiro, Y. Seto, M. Fukuma, K. Dan, and S. Toyoshima. N-(Cyclohexylcarbonyl)-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2. J. Med. Chem. 32:1436-1441 (1989).
2. Y. Sato, M. Nishikawa, H. Shinkai, and E. Sukegawa. Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals. Diabetes Res. Clin. Pract. 12:53-60 (1991).
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329:977-986 (1993).
4. M. Hu and R. T. Borchardt. Mechanism of L-α-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm. Res. 7:1313-1319 (1990).
5. I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749 (1989).
6. A. R. Hilgers, R. A. Conradi, and P. S. Burton. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 7:902-910 (1990).
7. I. J. Hidalgo and R. T. Borchardt. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim. Biophys. Acta 1028:25-30 (1990).
8. Y. Sato, M. Nishikawa, and H. Shinkai. High performance liquid chromatographic method for quantitation of a new antidiabetic agent in plasma. J. Liq. Chromatogr. 11:3425-3433 (1988).
9. L. Z. Benet and R. L. Galeazzi. Noncompartmental determination of the steady-state volume of distribution. J. Pharm. Sci. 68:1071-1074 (1979).
10. SAS Statistical Analysis System (version 6), SAS Institute Inc., Cary, NC, 1988.
11. W.-C. Yen and V. H. L. Lee. Paracellular transport of a proteolytically labile pentapeptide across the colonic and other intestinal segments of the albino rabbit: implications for peptide drug design. J. Controlled Release 28:97-109 (1994).
12. I. Osiecka, M. Cortese, P. A. Porter, R. T. Borchardt, J. A. Fix, and C. R. Gardner. Intestinal absorption of α-methyldopa: in vitro mechanistic studies in rat small intestinal segments. J. Pharmacol. Exp. Ther. 242:443-449 (1987).
13. A. Melander. Influence of food on the bioavailability of drugs. Clin. Pharmacokinet. 3:337-351 (1978).
14. P. G. Welling and F. L. S. Tse. The influence of food on the absorption of antimicrobial agents. J. Antimicrob. Chemother. 9:7-27 (1982).